What specific legal action did DSM-Firmenich take in China regarding its sclareol patent?

DSM-Firmenich AG initiated patent infringement litigation before the Xiong’An New District Court of Hebei Province, China, against multiple Chinese entities—including a sclareol producer and a research institute—alleging unauthorized use of its patent for the production of sclareol, an intermediate used to produce amber ingredients; the company requested the court to order the defendants to cease such use and provide compensation for the alleged infringement.

Why is DSM-Firmenich enforcing its sclareol patent rights in China, according to its official statement?

According to Amaury Roquette, Executive Vice President of Perfumery and Beauty Ingredients at DSM-Firmenich, the company is acting due to the strength of its IP position in sclareol and sclareol-derived products, and remains committed to taking all necessary legal actions to ensure its exclusive rights are respected, protect its significant investments in innovation, and safeguard its clients globally.

ChemBrief

Topics Daily Digest Tags

DSM-Firmenich Takes Legal Action Against Chinese Entities Over Sclareol Patent

Aug 21, 2026

DSM-Firmenich initiated patent infringement litigation in China against multiple entities regarding unauthorized sclareol production. The company seeks court orders to cease infringement and secure compensation for protecting its intellectual property rights.

chemweek

2025-10-30

DSM-Firmenich misses estimates on currency effects, trims guidance

2025-12-03

DSM-Firmenich completes €1.08B share buyback program

2026-01-28

DSM-Firmenich, Korea’s ASTech Forge Partnership to Advance Global UV Filters Market

2026-02-09

Private Equity Firm CVC to Acquire DSM-Firmenich’s Animal Nutrition and Health Business for €2.2 Billion

2026-02-12

DSM-Firmenich Q4 Earnings Decline Attributed to Currency Effects